Evaluation of betahistine for the prevention of seasickness: Effect on vestibular function, psychomotor performance and efficacy at sea

Journal of Vestibular Research: Equilibrium and Orientation

Volumn 13, Issue 2-3, 2003, Pages 103-111

  Gordon, Carlos R ^a,b,c   Doweck, Ilana ^a   Nachum, Zohar ^a   Gonen, Adi ^a   Spitzer, Orna ^a   Shupak, Avi ^a  

^a ISRAEL NAVAL MEDICAL INSTITUTE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Betahistine; Motion sickness; Seasickness

Indexed keywords

BETAHISTINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EVALUATION; HUMAN; LABORATORY TEST; MALE; MOTION SICKNESS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEA; SIDE EFFECT; STATISTICAL ANALYSIS; TASK PERFORMANCE; TRAVEL; VESTIBULAR FUNCTION; VESTIBULOOCULAR REFLEX;

ADULT; BETAHISTINE; CROSS-OVER STUDIES; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; HISTAMINE AGONISTS; HUMANS; MALE; MOTION SICKNESS; OCEANS AND SEAS; PSYCHOMOTOR PERFORMANCE; REFLEX, VESTIBULO-OCULAR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VESTIBULAR FUNCTION TESTS;

EID: 0345830628     PISSN: 09574271     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. J.T. Reason and J.J. Brand, Motion Sickness, London, Academic Press, 1975.
2. C.D. Wood, Pharmacological countermeasures against motion sickness, in: Motion and Space Sickness, G.H. Crampton, ed., Boca Raton, FL, CRC Press, 1990, pp. 343-351.
3. N. Takeda, M. Morita, S. Hasegawa, A. Horii, T. Kubo and T. Matsunaga, Neuropharmacology of motion sickness and emesis. A review, Acta Otolaryngol (Stockh) Suppl 501 (1993), 10-15.
4. C.D. Wood, J.E. Manno, B.R. Manno, H.M. Redetzki, M.J. Wood and M.E. Mims, Evaluation of antimotion sickness drug side effects on performance, Aviat Space Environ Med 56 (1985), 310-316.
5. J.-M. Arrang, M. Garbarg, T.T. Quach, M. Dam Trung Tuong, E. Yeramian and J.C. Schwartz, Actions of betahistine at histamine receptors in the brain, Eur J Pharmacol 111 (1985), 73-84.
6. B. Tighilet, J. Leonard and M. Lacour, Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat, J Vestib Res 5 (1995), 53-66.
7. J.-J. Wang and M.B. Dutia, Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness, Exp Brain Res 105 (1995), 18-24.
8. B. Tighilet, S. Trottier, C. Mourre, C. Chotard and M. Lacour, Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms, Eur J Pharmacol 446 (2002), 63-73.
9. P. Valli, Betahistine reduces the resting firing rate of vestibular receptors in the frog, Acta Otolaryngol (Stockh) Suppl 544 (2000), 8-10.
10. E. Soto, H. Chavez, P. Valli, C. Benvenuti and R. Vega, Betahistine produces post-synaptic inhibition of the excitability of the primary afferent neurons in the vestibular endorgans, Acta Otolaryngol (Stockh) Suppl 545 (2001), 19-24.
11. B. Fraysse, J.P. Bebear, C. Dubreuil, C. Berges and R. Dauman, Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Meniere's disease, Acta Otolaryngol (Stockh) Suppl 490 (1991), 1-10.
12. J.T. Schmidt and E.H. Huizing, The clinical drug trial in Meniere's disease with emphasis on the effect of betahistine SR, Acta Otolaryngol (Stockh) Suppl 497 (1992), 1-189.
13. J.K. Dziadziola, E.L. Laurikainen, J.D. Rachel and W.S. Quirk, Betahistine increases vestibular blood flow, Otolaryngol Head Neck Surg 120 (1999), 400-405.
14. W.J. Oosterveld, Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study, J Laryngol Otol 98 (1984), 37-41.
15. V. Colletti, Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation, Acta Otolaryngol (Stockh) Suppl 544 (2000), 27-33.
16. J.E.F. Reynolds, ed., Martindale. The extra pharmacopeia, 32nd ed. London: Royal Pharmaceutical Society, 1999, pp. 1553.
17. A. Shupak, D. Kerem, C. Gordon, O. Spitzer, N. Mendelowitz and Y. Melamed, Vestibulo-ocular reflex as a parameter of seasickness susceptibility, Ann Otol Rhinol Laryngol 99 (1990), 131-136.
18. I. Doweck, C.R. Gordon, O. Spitzer, Y. Melamed and A. Shupak, The vestibulo-ocular reflex (VOR) under the influence of cinnarizine, J Vestib Res 4 (1994), 215-220.
19. C.R. Gordon, O. Spitzer, I. Doweck, A. Shupak and N. Gadoth, The vestibulo-ocular reflex and seasickness susceptibility, J Vestib Res 6 (1996), 229-233.
20. J.W. Wolfe, E.J. Engelken and C.M. Kos, Low-frequency harmonic acceleration as a test of labyrinthine function: basic methods and illustrative cases, Otolaryngology 86 (1978), ORL130-142.
21. C.R. Gordon, A. Gonen, Z. Nachum, I. Doweck, O. Spitzer and A. Shupak, The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance, J Psychopharmacol 15 (2001), 167-172.
22. L. Moser, K.J. Huther, J. Koch-Weser and P.V. Lundt, Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings, Eur J Clin Pharmacol 14 (1978), 417-423.
23. G. Schuhfried, The PC/S Vienna Test System, Modling, Austria, Dr G. Schuhfried GmbH, 1992.
24. D. Wechsler, The Measurement and Appraisal of Adult Intelligence, Baltimore, Williams & Wilkins, 1958.
25. S. Weintraub and M.-M. Mesulam, Mental state assessment of young and elderly adults in behavioral neurology, in: Principles of Behavioral Neurology, Contemporary Neurology Series, (No. 26), M.-M. Mesulam, ed., Philadelphia, FA Davis, 1985, pp. 71-123.
26. S.F. Wiker, R.S. Kennedy, M.E. McCauley and R.L. Pepper, Susceptibility to seasickness: influence of hull design and steaming direction, Aviat Space Environ Med 50 (1979), 1046-1051.
27. S.F. Wiker, R.S. Kennedy, M.E. McCauley and R.L. Pepper, Reliability, Validity and Application of an Improved Scale for Assessment of Motion Sickness Severity, (Report No. CG-D-29-79), Washington, DC, US Department of Transportation, United States Coast Guard, Office of Research and Development, 1979.
28. I. Doweck, C.R. Gordon, O. Spitzer, Y. Melamed and A. Shupak, Effect of cinnarizine in the prevention of seasickness, Aviat Space Environ Med 65 (1994), 606-609.
29. A. Shupak, I. Doweck, C.R. Gordon and O. Spitzer, Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study, Clin Pharmacol Ther 55 (1994), 670-680.
30. W.J. Oosterveld, Effect of betahistine dihydrochloride on induced vestibular nystagmus: a double blind study, Clin Otolaryngol 12 (1987), 131-135.
31. H. Kingma, M. Bonink, A. Meulenbroeks and H. Konijnenberg, Dose-dependent effect of betahistine on the vestibulo-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo, Acta Otolaryngol (Stockh) 117 (1997), 641-646.
32. T. Betts, D. Harris and E. Gadd, The effects of two anti-vertigo drugs (betahistine and prochlorperazine) on driving skills, Br J Clin Pharmacol 32 (1991), 455-458.